Investments: Cormorant Asset Management, LP

Absolutes institutionelles Investment pro Aktie über die letzten 4 Quartale (13F-Daten). — Filter: Cormorant Asset Management, LP
Details & Interpretation
Spalten: Investment ($) = Gesamtwert aller institutionellen Positionen in USD. QoQ Veränd. = Differenz zum Vorquartal. Anz. Fonds = Anzahl investierender Fonds. Breite = Veränderung der Halter-Breite (distinct Fonds) über das Fenster — ▲ steigend / ▼ fallend (Interesse = Flow, nicht Kurs). GCS = aktuelles Conviction-Band der Aktie.
Klick auf Aktie öffnet den Detail-Report mit allen einzelnen Fondsgesellschaften.
Eine Auswahl wendet den Filter sofort an; per Tastatur mit Enter bestätigen.
Fonds:
AktieTickerBreiteGCS2026/Q32026/Q22026/Q12025/Q4
Investment ($)QoQ ($)QoQ (%)Anz. FondsInvestment ($)QoQ ($)QoQ (%)Anz. FondsInvestment ($)QoQ ($)QoQ (%)Anz. FondsInvestment ($)QoQ ($)QoQ (%)Anz. Fonds
Gesamt1.489.258.905 $-453.669.658 $
-31,2 %
601.951.406.063 $+68.903.113 $
-7,9 %
501.991.046.371 $+288.653.594 $
+455,7 %
462.162.580.277 $+869.702.629 $
+42,1 %
35
Praxis Precision Medicines, Inc.PRAX→ 0Neutral145.615.000 $-68.650.600 $
-32,0 %
1214.265.600 $-71.033.645 $
-24,9 %
1285.299.245 $+5.296.245 $
+1,9 %
1280.003.000 $+227.003.000 $
+428,3 %
1
BridgeBio Oncology Therapeutics, Inc.BBOT→ 0Schwach73.302.235 $-62.932.651 $
-46,2 %
1136.234.886 $-23.778.530 $
-14,9 %
1160.013.416 $-63.826.581 $
-28,5 %
1223.839.997 $+16.805.878 $
+8,1 %
1
Abivax S.A.ABVX→ 0Neutral42.083.500 $-47.867.000 $
-53,2 %
189.950.500 $+5.324.500 $
+6,3 %
184.626.000 $-97.428.250 $
-53,5 %
1182.054.250 $+16.499.250 $
+10,0 %
1
INVESCO QQQ TRUST, SERIES 1QQQ→ 0153.577.500 $+153.577.500 $1
EyePoint, Inc.EYPT→ 0Sehr schwach18.802.500 $-81.297.500 $
-81,2 %
1100.100.000 $-6.435.850 $
-6,0 %
1106.535.850 $-44.465.700 $
-29,4 %
1151.001.550 $+32.453.550 $
+27,4 %
1
Parabilis Medicines, Inc.PBLS→ 0Neutral149.038.111 $+22.708.811 $
+18,0 %
1126.329.300 $+126.329.300 $1
iSHARES TRUST→ 0123.080.000 $+123.080.000 $1
SPDR SERIES TRUST→ 0121.930.000 $+121.930.000 $1
Rapport Therapeutics, Inc.RAPP→ 0Neutral82.572.706 $-28.166.194 $
-25,4 %
1110.738.900 $+18.198.068 $
+19,7 %
192.540.832 $+685.845 $
+0,7 %
191.854.987 $-2.962.887 $
-3,1 %
1
Erasca, Inc.ERAS→ 0Neutral73.300.000 $-36.620.000 $
-33,3 %
1109.920.000 $+16.076.000 $
+17,1 %
193.844.000 $+93.844.000 $1
Edgewise Therapeutics, Inc.EWTX→ 0Neutral75.516.000 $-26.465.300 $
-26,0 %
1101.981.300 $-708.700 $
-0,7 %
1102.690.000 $+21.172.725 $
+26,0 %
181.517.275 $+16.475.075 $
+25,3 %
1
ALUMIS INC.ALMS→ 0Neutral15.334.250 $-77.122.421 $
-83,4 %
192.456.671 $+5.454.892 $
+6,3 %
187.001.779 $+51.518.362 $
+145,2 %
135.483.417 $+26.915.307 $
+314,1 %
1
BridgeBio Pharma, Inc.BBIO→ 0Neutral16.450.000 $-24.514.000 $
-59,8 %
140.964.000 $-22.157.000 $
-35,1 %
163.121.000 $-28.667.000 $
-31,2 %
191.788.000 $+19.072.000 $
+26,2 %
1
MoonLake ImmunotherapeuticsMLTX→ 0Neutral33.408.566 $-29.001.215 $
-46,5 %
162.409.781 $-21.105.490 $
-25,3 %
183.515.271 $+26.110.664 $
+45,5 %
157.404.607 $+43.106.387 $
+301,5 %
1
BRIGHT MINDS BIOSCIENCES INC.DRUG→ 0Schwach39.856.000 $-23.324.000 $
-36,9 %
163.180.000 $-14.119.383 $
-18,3 %
177.299.383 $-5.370.808 $
-6,5 %
182.670.191 $+18.411.173 $
+28,7 %
1
Dianthus Therapeutics, Inc. /DE/DNTH→ 0Schwach44.025.000 $-29.085.000 $
-39,8 %
173.110.000 $-6.614.000 $
-8,3 %
179.724.000 $+79.724.000 $1
Olema Oncology, Inc.OLMA→ 0Neutral15.120.000 $-11.776.500 $
-43,8 %
126.896.500 $-38.707.500 $
-59,0 %
165.604.000 $-3.146.000 $
-4,6 %
168.750.000 $+68.750.000 $1
BlossomHill Therapeutics, Inc.BLSM→ 067.365.594 $+67.365.594 $1
Adlai Nortye Group Ltd.ANL→ 0Neutral63.651.664 $+17.902.030 $
+39,1 %
145.749.634 $+25.696.464 $
+128,1 %
120.053.170 $+20.053.170 $1
BioAge Labs, Inc.BIOA→ 0Neutral15.885.889 $-42.707.840 $
-72,9 %
158.593.729 $+8.037.048 $
+15,9 %
150.556.681 $+23.559.477 $
+87,3 %
126.997.204 $+14.410.447 $
+114,5 %
1
Oruka Therapeutics, Inc.ORKA→ 0Neutral33.316.000 $-17.441.968 $
-34,4 %
150.757.968 $+24.597.641 $
+94,0 %
126.160.327 $+9.994.792 $
+61,8 %
116.165.535 $+5.909.407 $
+57,6 %
1
INSMED IncINSM→ 0Schwach2.282.800 $-5.713.700 $
-71,5 %
17.996.500 $-23.072.300 $
-74,3 %
131.068.800 $-16.792.200 $
-35,1 %
147.861.000 $-14.063.300 $
-22,7 %
1
Centessa Pharmaceuticals plcCNTA→ 041.706.000 $+8.567.750 $
+25,9 %
133.138.250 $-13.543.000 $
-29,0 %
1
Tango Therapeutics, Inc.TNGX→ 0Schwach17.465.000 $-23.173.000 $
-57,0 %
140.638.000 $+10.827.000 $
+36,3 %
129.811.000 $+29.811.000 $1
Damora Therapeutics, Inc.DMRA→ 0Neutral17.024.000 $-8.986.000 $
-34,5 %
126.010.000 $-13.487.500 $
-34,1 %
139.497.500 $+39.497.500 $1
Biohaven Ltd.BHVN→ 0Neutral20.158.500 $-18.678.300 $
-48,1 %
138.836.800 $+23.947.200 $
+160,8 %
114.889.600 $+14.776.700 $
+13.088,3 %
1112.900 $-37.200 $
-24,8 %
1
Electra Therapeutics, Inc.ETRA→ 0Neutral37.862.249 $+37.862.249 $1
enGene Therapeutics Inc.ENGN→ 0Schwach36.120.000 $+20.249.846 $
+127,6 %
1
MBX Biosciences, Inc.MBX→ 0Neutral21.982.500 $-8.377.500 $
-27,6 %
130.360.000 $-3.072.000 $
-9,2 %
133.432.000 $-1.892.800 $
-5,4 %
135.324.800 $+13.887.300 $
+64,8 %
1
NewAmsterdam Pharma Co N.V.NAMS→ 0Schwach2.432.000 $-14.513.000 $
-85,6 %
116.945.000 $-13.464.500 $
-44,3 %
130.409.500 $-4.670.500 $
-13,3 %
135.080.000 $-26.777.000 $
-43,3 %
1
AgomAb Therapeutics NVAGMB→ 0Neutral27.365.363 $-4.634.854 $
-14,5 %
132.000.217 $+6.138.716 $
+23,7 %
125.861.501 $+25.861.501 $1
Attovia Therapeutics, Inc.ATTO→ 0Neutral30.660.285 $+30.660.285 $1
Faeth Therapeutics, Inc.FTH→ 0Schwach30.579.917 $+22.924.367 $
+299,4 %
17.655.550 $-1.996.567 $
-20,7 %
19.652.117 $+9.652.117 $1
Latigo Biotherapeutics, Inc.LTGO→ 030.322.858 $+30.322.858 $1
Pharvaris N.V.PHVS→ 0Neutral14.274.000 $-11.661.000 $
-45,0 %
125.935.000 $-2.315.000 $
-8,2 %
128.250.000 $-1.803.250 $
-6,0 %
130.053.250 $-3.958.590 $
-11,6 %
1
Climb Bio, Inc.CLYM→ 0Schwach24.155.820 $-3.306.420 $
-12,0 %
127.462.240 $+27.462.240 $1
Opus Genetics, Inc.IRD→ 0Neutral26.620.000 $+26.620.000 $1
Freenome, Inc.FRNM→ 0Schwach22.538.754 $+22.538.754 $1
Maze Therapeutics, Inc.MAZE→ 0Neutral22.387.500 $+22.387.500 $1
Corbus Pharmaceuticals Holdings, Inc.CRBP→ 0Neutral15.992.702 $-6.003.126 $
-27,3 %
121.995.828 $-23.450 $
-0,1 %
122.019.278 $+2.931.214 $
+15,4 %
119.088.064 $-10.955.686 $
-36,5 %
1
Ascendis Pharma A/SASND→ 0Stark3.417.450 $-9.918.550 $
-74,4 %
113.336.000 $-8.393.350 $
-38,6 %
121.729.350 $+405.350 $
+1,9 %
121.324.000 $+21.324.000 $1
Roivant Sciences Ltd.ROIV→ 0Neutral3.657.000 $-13.153.250 $
-78,2 %
116.810.250 $-3.964.750 $
-19,1 %
120.775.000 $+20.775.000 $1
Tarsus Pharmaceuticals, Inc.TARS→ 0Neutral3.930.500 $-2.363.500 $
-37,6 %
16.294.000 $-9.489.750 $
-60,1 %
115.783.750 $-4.686.250 $
-22,9 %
120.470.000 $+2.641.000 $
+14,8 %
1
Spyre Therapeutics, Inc.SYRE→ 0Neutral11.128.750 $-8.846.750 $
-44,3 %
119.975.500 $+19.975.500 $1
ADARx Pharmaceuticals, Inc.ADRX→ 0Neutral19.200.176 $+19.200.176 $1
Definium Therapeutics, Inc.DFTX→ 0Neutral10.466.500 $-8.349.500 $
-44,4 %
118.816.000 $+18.816.000 $1
GH Research PLCGHRS→ 0Neutral16.510.000 $-10.895.078 $
-39,8 %
1
Cue Biopharma, Inc.CUE→ 0Schwach16.176.123 $+16.176.123 $1
Terns Pharmaceuticals, Inc.TERN→ 015.816.000 $+15.816.000 $1
Cabaletta Bio, Inc.CABA→ 0Neutral8.640.000 $-6.910.000 $
-44,4 %
115.550.000 $+755.000 $
+5,1 %
114.795.000 $+5.159.000 $
+53,5 %
19.636.000 $-2.064.000 $
-17,6 %
1
Arcutis Biotherapeutics, Inc.ARQT→ 0Neutral1.321.500 $-3.267.000 $
-71,2 %
14.588.500 $-6.013.500 $
-56,7 %
110.602.000 $-3.918.000 $
-27,0 %
114.520.000 $-88.750 $
-0,6 %
1
Crinetics Pharmaceuticals, Inc.CRNX→ 04.677.500 $-4.402.500 $
-48,5 %
19.080.000 $-4.885.000 $
-35,0 %
113.965.000 $-2.695.000 $
-16,2 %
1
Helix Acquisition Corp. IIIHLXC→ 013.779.450 $-25.950 $
-0,2 %
113.805.400 $+622.800 $
+4,7 %
113.182.600 $+13.182.600 $1
Axsome Therapeutics, Inc.AXSM→ 0Neutral8.451.000 $-5.247.000 $
-38,3 %
113.698.000 $+1.553.000 $
+12,8 %
1
Kailera Therapeutics, Inc.KLRA→ 0Neutral4.568.000 $-7.548.500 $
-62,3 %
112.116.500 $+12.116.500 $1
Aclaris Therapeutics, Inc.ACRS→ 0Schwach9.205.000 $+9.205.000 $1
Janux Therapeutics, Inc.JANX→ 0Sehr schwach8.970.000 $-11.804.000 $
-56,8 %
1
Amylyx Pharmaceuticals, Inc.AMLX→ 0Neutral8.730.000 $+5.138.000 $
+143,0 %
13.592.000 $-1.273.000 $
-26,2 %
14.865.000 $+33.000 $
+0,7 %
14.832.000 $-1.963.000 $
-28,9 %
1
Zura Bio LtdZURA→ 0Schwach8.627.500 $+8.627.500 $1
Structure Therapeutics Inc.GPCR→ 0Neutral938.100 $-3.087.150 $
-76,7 %
14.025.250 $-4.409.750 $
-52,3 %
18.435.000 $+8.435.000 $1
Cogent Biosciences, Inc.COGT→ 0Neutral960.600 $-2.909.400 $
-75,2 %
13.870.000 $-3.828.000 $
-49,7 %
17.698.000 $-294.000 $
-3,7 %
17.992.000 $+7.992.000 $1
Enliven Therapeutics, Inc.ELVN→ 0Neutral3.438.000 $-4.174.500 $
-54,8 %
17.612.500 $+7.612.500 $1
Monte Rosa Therapeutics, Inc.GLUE→ 0Schwach6.580.000 $+6.580.000 $1
ARROWHEAD PHARMACEUTICALS, INC.ARWR→ 0Neutral981.750 $-3.093.750 $
-75,9 %
14.075.500 $-2.194.500 $
-35,0 %
16.270.000 $+6.270.000 $1
iBio, Inc.IBIO→ 0Neutral4.212.600 $-2.034.900 $
-32,6 %
16.247.500 $+6.247.500 $1
Vaxcyte, Inc.PCVX→ 0Schwach853.500 $-2.053.000 $
-70,6 %
12.906.500 $-2.904.500 $
-50,0 %
15.811.000 $+43.500 $
+0,8 %
15.767.500 $-536.000 $
-8,5 %
1
Inhibrx Biosciences, Inc.INBX→ 0Sehr schwach5.004.000 $+5.004.000 $1
Jade Biosciences, Inc.JBIO→ 0Schwach4.215.000 $+4.215.000 $1
Research Alliance Corp IIIRACC→ 0Neutral1.353.750 $-2.605.250 $
-65,8 %
13.959.000 $+3.959.000 $1
Altimmune, Inc.ALT→ 0Neutral3.800.000 $+3.800.000 $1
Rallybio CorpRLYB→ 0Stark3.588.000 $+3.588.000 $1
Odyssey Therapeutics, Inc.ODTX→ 0Neutral2.777.500 $-496.750 $
-15,2 %
13.274.250 $+3.274.250 $1
Boundless Bio, Inc.BOLD→ 0Neutral2.359.400 $-140.600 $
-5,6 %
12.500.000 $+2.500.000 $1
Braveheart Bio, Inc.BRVE→ 01.414.000 $+1.414.000 $1
Context Therapeutics Inc.CNTX→ 0Neutral1.387.421 $+1.387.421 $1
IRulya Therapeutics Inc.IRLA→ 0Sehr schwach170.493 $+70.484 $
+70,5 %
1100.009 $+100.009 $1
Gesamt1.489.258.905 $-453.669.658 $
-31,2 %
601.951.406.063 $+68.903.113 $
-7,9 %
501.991.046.371 $+288.653.594 $
+455,7 %
462.162.580.277 $+869.702.629 $
+42,1 %
35
Erweitert ×